Boston University scientists developed an AI model that predicts Alzheimer's-related protein levels using brain imaging and clinical data.
Key Details
- 1AI tool predicts presence of amyloid beta and tau proteins linked to Alzheimer's disease.
- 2Model incorporates brain scans, cognitive scores, genetics, and health history from 12,185 participants across seven cohorts.
- 3Tool provides location-specific brain information, unlike most blood tests.
- 4Successfully validated on a separate international cohort, showing robust predictive performance.
- 5Aims to enable earlier, cheaper, and more accessible Alzheimer's detection and staging.
- 6Published in Nature Communications on August 11, 2025.
Why It Matters
Accurate, cost-effective early detection of Alzheimer's using non-invasive imaging and AI could transform patient care and expedite selection for clinical trials. This approach highlights the expanding role of imaging AI in neurological disease diagnosis and management.
Source
EurekAlert
Related News
•EurekAlert
Deep Learning AI Outperforms Clinic Prognostics for Colorectal Cancer Recurrence
A new deep learning model using histopathology images identifies recurrence risk in stage II colorectal cancer more effectively than standard clinical predictors.
•EurekAlert
AI Reveals Key Health System Levers for Cancer Outcomes Globally
AI-based analysis identifies the most impactful policy and resource factors for improving cancer survival across 185 countries.
•EurekAlert
Dual-Branch Graph Attention Network Predicts ECT Success in Teen Depression
Researchers developed a dual-branch graph attention network that uses structural and functional MRI data to accurately predict individual responses to electroconvulsive therapy in adolescents with major depressive disorder.